Skip To Main Content
This website is intended exclusively for healthcare professionals residing and/or working in Qatar.
Campus
Campus
Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content

IL-4/IL-13 Dual Cytokine Signaling in Severe Asthma: Mechanistic Insights by Prof. Kenneth Chapman

Recognizing the key cytokines driving type 2 inflammation and understanding their profound impact on patients’ asthma burden is crucial.1-3

Learn more

GOLD 2026 Report: Key Updates for COPD Management

What’s New in the GOLD 2026 Report

Learn more

Expanding RSV Protection in Kuwait: New National Directives for Monoclonal Antibody Use

Summary of Kuwait’s updated RSV prevention policy

Learn more

Understanding Kaplan–Meier Curves in MS: An Overview with Dr. Barry Singer

Learn more

Understanding 6‑Month CDP in MS: An Overview with Dr. Barry Singer

Learn more

Understanding PIRA in MS: An Overview with Dr. Barry Singer

Learn more

Rare Disease Academy 2.0/ Spotting the Signs: A guide to Early Diagnosis and a Timely Refferals

Learn more

Advancing the Standard of Care: Addressing Progression in MS

An evidence-based exploration of the current MS landscape, focusing on the pathophysiology of Progression Independent of Relapse Activity (PIRA). This module examines the clinical significance of disability accumulation and the remaining unmet needs in long-term patient management.

Learn more

IL-4, IL-13, AND IL-5 ARE DRIVERS OF SYSTEMIC TYPE 2 INFLAMMATION

Eosinophilic inflammation has multiple drivers1,2

Learn more

Charting New Course: The Frontier of Early Intervention and Disease Modification in AD

Learn more

Type II Summit 2025

Video Showcasing the Type II Summit 2025

Learn more

Early Intervention and Disease Modification in Atopic Dermatitis

Learn more